TCTR20210226002已完成不适用
SARS-CoV-2-specific immune responses after COVID-19 vaccination in end-stage renal disease patients and kidney transplant recipients
ational Research Council of Thailand (NRCT).0 个研究点目标入组 120 人开始时间: 2021年2月26日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
Our findings revealed weak HMI but comparable CMI responses in fully vaccinated KT recipients receiving inactivated SARS-CoV-2 vaccination compared to immunocompetent individuals.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 70 Years（—）
- 性别
- All
入选标准
- •Healthy subjects, ESRD patients, or kidney transplant recipients who are willing to participate in the project.
排除标准
- •Those who received the COVID-19 vaccine prior to
研究者
相似试验
已完成
4 期
SARS-CoV-2-specific immune responses after COVID-19 vaccination in solid organ transplant recipientsCOVID-19Humoral immunity, cell-mediated immunity, COVID-19, immunocompromisedTCTR20210523002Faculty of Medicine Ramathibodi Hospital250
已完成
不适用
SARS-CoV-2 Specific Immune Response After COVID-19 Vaccination in Cancer PatientsCOVID-19CancerNCT05313074National Cancer Institute, Thailand311
已完成
4 期
SARS-CoV-2-specific immune responses after two versus three doses COVID-19 vaccination in end-stage renal disease patients and kidney transplant recipientsCOVID-19renal transplant, immunogenicity, safety, humoral immunity, cell-mediated immunityTCTR20210524002Faculty of Medicine Ramathibodi Hospital, Mahidol University120
撤回
不适用
Evaluation of Post-SARS-CoV-2 Vaccinal Response in Immunocompromised PatientsHIV SeropositivityVaccination ReactionCovid19ImmunodeficiencyNCT05672654University Hospital, Ghent
终止
不适用
Immune Response After SARS-CoV-2 (COVID-19) Vaccination in a Context of Non-Hodgkin LymphomaNon-hodgkin Lymphoma,B CellVaccination FailureNCT05050461Versailles Hospital120